Myosin7a Deficiency Results in Reduced Retinal Activity Which Is Improved by Gene Therapy

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Colella, Pasqualina ^a   Sommella, Andrea ^a   Marrocco, Elena ^a   Di Vicino, Umberto ^a   Polishchuk, Elena ^a   Garrido, Marina Garcia ^b   Seeliger, Mathias W ^b   Polishchuk, Roman ^a   Auricchio, Alberto ^a,c  

^a TELETHON INSTITUTE OF GENETICS AND MEDICINE TIGEM   (Italy)

^b Centre for Ophthalmology   (Germany)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MYOSIN; MYOSIN7A; UNCLASSIFIED DRUG; VISUAL PIGMENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B WAVE; CONTROLLED STUDY; DESENSITIZATION; DRUG EFFICACY; ELECTRORETINOGRAM; GENE EXPRESSION; GENE MUTATION; GENE THERAPY; GENE TRANSFER; GENETIC HETEROGENEITY; MOUSE; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; PHENOTYPE; PHOTORECEPTOR; PIGMENT EPITHELIUM; PROTEIN DEFICIENCY; RETINA DEGENERATION; RETINITIS PIGMENTOSA; SCANNING LASER OPHTHALMOSCOPY; SENSITIVITY ANALYSIS; USHER SYNDROME;

ADULT; ANIMALS; BLOTTING, WESTERN; DEPENDOVIRUS; DISEASE MODELS, ANIMAL; ELECTRORETINOGRAPHY; EYE; FEMALE; GENETIC THERAPY; GENETIC VECTORS; HEK293 CELLS; HUMANS; MALE; MELANOSOMES; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, KNOCKOUT; MICROSCOPY, ELECTRON; MYOSINS; RETINA; RETINAL DEGENERATION; USHER SYNDROMES;

EID: 84883201525     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072027     Document Type: Article

References (63)

1. Millan JM, Aller E, Jaijo T, Blanco-Kelly F, Gimenez-Pardo A, et al. (2011) An update on the genetics of usher syndrome. J Ophthalmol 2011: 417217.
2. Hashimoto T, Gibbs D, Lillo C, Azarian SM, Legacki E, et al. (2007) Lentiviral gene replacement therapy of retinas in a mouse model for Usher syndrome type 1B. Gene Ther 14: 584-594.
3. Gibson F, Walsh J, Mburu P, Varela A, Brown KA, et al. (1995) A type VII myosin encoded by the mouse deafness gene shaker-1. Nature 374: 62-64.
4. Self T, Mahony M, Fleming J, Walsh J, Brown SD, et al. (1998) Shaker-1 mutations reveal roles for myosin VIIA in both development and function of cochlear hair cells. Development 125: 557-566.
5. Saw D Jr, Steel KP, Brown SD, (1997) Shaker mice and a peek into the House of Usher. Exp Anim 46: 1-9.
6. Smits BM, Peters TA, Mul JD, Croes HJ, Fransen JA, et al. (2005) Identification of a rat model for usher syndrome type 1B by N-ethyl-N-nitrosourea mutagenesis-driven forward genetics. Genetics 170: 1887-1896.
7. Libby RT, Steel KP, (2001) Electroretinographic anomalies in mice with mutations in Myo7a, the gene involved in human Usher syndrome type 1B. Invest Ophthalmol Vis Sci 42: 770-778.
8. Lillo C, Kitamoto J, Liu X, Quint E, Steel KP, et al. (2003) Mouse models for Usher syndrome 1B. Adv Exp Med Biol 533: 143-150.
9. Lopes VS, Gibbs D, Libby RT, Aleman TS, Welch DL, et al. (2011) The Usher 1B protein, MYO7A, is required for normal localization and function of the visual retinoid cycle enzyme, RPE65. Hum Mol Genet 20: 2560-2570.
10. Peng YW, Zallocchi M, Wang WM, Delimont D, Cosgrove D, (2011) Moderate light-induced degeneration of rod photoreceptors with delayed transducin translocation in shaker1 mice. Invest Ophthalmol Vis Sci 52: 6421-6427.
11. Hasson T, Heintzelman MB, Santos-Sacchi J, Corey DP, Mooseker MS, (1995) Expression in cochlea and retina of myosin VIIa, the gene product defective in Usher syndrome type 1B. Proc Natl Acad Sci U S A 92: 9815-9819.
12. Liu X, Vansant G, Udovichenko IP, Wolfrum U, Williams DS, (1997) Myosin VIIa, the product of the Usher 1B syndrome gene, is concentrated in the connecting cilia of photoreceptor cells. Cell Motil Cytoskeleton 37: 240-252.
13. Gibbs D, Diemer T, Khanobdee K, Hu J, Bok D, et al. (2010) Function of MYO7A in the human RPE and the validity of shaker1 mice as a model for Usher syndrome 1B. Invest Ophthalmol Vis Sci 51: 1130-1135.
14. Liu X, Udovichenko IP, Brown SD, Steel KP, Williams DS, (1999) Myosin VIIa participates in opsin transport through the photoreceptor cilium. J Neurosci 19: 6267-6274.
15. Liu X, Williams DS, (2001) Coincident onset of expression of myosin VIIa and opsin in the cilium of the developing photoreceptor cell. Exp Eye Res 72: 351-355.
16. Liu X, Ondek B, Williams DS, (1998) Mutant myosin VIIa causes defective melanosome distribution in the RPE of shaker-1 mice. Nat Genet 19: 117-118.
17. Gibbs D, Azarian SM, Lillo C, Kitamoto J, Klomp AE, et al. (2004) Role of myosin VIIa and Rab27a in the motility and localization of RPE melanosomes. J Cell Sci 117: 6473-6483.
18. Gibbs D, Kitamoto J, Williams DS, (2003) Abnormal phagocytosis by retinal pigmented epithelium that lacks myosin VIIa, the Usher syndrome 1B protein. Proc Natl Acad Sci U S A 100: 6481-6486.
19. Tsilou ET, Rubin BI, Caruso RC, Reed GF, Pikus A, et al. (2002) Usher syndrome clinical types I and II: could ocular symptoms and signs differentiate between the two types? Acta Ophthalmol Scand 80: 196-201.
20. Jacobson SG, Cideciyan AV, Gibbs D, Sumaroka A, Roman AJ, et al. (2011) Retinal disease course in Usher syndrome 1B due to MYO7A mutations. Invest Ophthalmol Vis Sci 52: 7924-7936.
21. Sahly I, Dufour E, Schietroma C, Michel V, Bahloul A, et al. (2012) Localization of Usher 1 proteins to the photoreceptor calyceal processes, which are absent from mice. J Cell Biol 199: 381-399.
22. Kalaitzis AA, Lawrence ND, (2011) A simple approach to ranking differentially expressed gene expression time courses through Gaussian process regression. BMC Bioinformatics 12: 180.
23. Venables VN, Ripley BD (2002) Modern Applied Statistics with S. New York: Springer Science+Business Media. 495p.
24. Mburu P, Liu XZ, Walsh J, Saw D Jr, Cope MJ, et al. (1997) Mutation analysis of the mouse myosin VIIA deafness gene. Genes Funct 1: 191-203.
25. Surace EM, Domenici L, Cortese K, Cotugno G, Di Vicino U, et al. (2005) Amelioration of both functional and morphological abnormalities in the retina of a mouse model of ocular albinism following AAV-mediated gene transfer. Mol Ther 12: 652-658.
26. Gargiulo A, Bonetti C, Montefusco S, Neglia S, Di Vicino U, et al. (2009) AAV-mediated tyrosinase gene transfer restores melanogenesis and retinal function in a model of oculo-cutaneous albinism type I (OCA1). Mol Ther 17: 1347-1354.
27. Allocca M, Doria M, Petrillo M, Colella P, Garcia-Hoyos M, et al. (2008) Serotype-dependent packaging of large genes in adeno-associated viral vectors results in effective gene delivery in mice. J Clin Invest 118: 1955-1964.
28. Auricchio A, Hildinger M, O'Connor E, Gao GP, Wilson JM, (2001) Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column. Hum Gene Ther 12: 71-76.
29. Mueller C, Ratner D, Zhong L, Esteves-Sena M, Gao G (2012) Production and discovery of novel recombinant adeno-associated viral vectors. Curr Protoc Microbiol Chapter 14: Unit14D 11.
30. Drittanti L, Rivet C, Manceau P, Danos O, Vega M, (2000) High throughput production, screening and analysis of adeno-associated viral vectors. Gene Ther 7: 924-929.
31. Liang FQ, Anand V, Maguire AM, Bennett J (2000) Intraocular delivery of recombinant virus. In: Rakoczy PE editor. Vision Research Protocols.Totowa: Humana Press Inc. 125-139.
32. Grieger JC, Samulski RJ, (2005) Packaging capacity of adeno-associated virus serotypes: impact of larger genomes on infectivity and postentry steps. J Virol 79: 9933-9944.
33. Monahan PE, Lothrop CD, Sun J, Hirsch ML, Kafri T, et al. (2010) Proteasome inhibitors enhance gene delivery by AAV virus vectors expressing large genomes in hemophilia mouse and dog models: a strategy for broad clinical application. Mol Ther 18: 1907-1916.
34. Sambrook J, Russell DW (2001) Molecular Cloning: a laboratory manual: New York: Cold Spring Harbor Laboratory Pres.2222 p.
35. Mironov AA, Beznoussenko GV, Nicoziani P, Martella O, Trucco A, et al. (2001) Small cargo proteins and large aggregates can traverse the Golgi by a common mechanism without leaving the lumen of cisternae. J Cell Biol 155: 1225-1238.
36. Fischer MD, Huber G, Paquet-Durand F, Humphries P, Redmond TM, et al. (2012) In vivo assessment of rodent retinal structure using spectral domain optical coherence tomography. Adv Exp Med Biol 723: 489-494.
37. Allocca M, Mussolino C, Garcia-Hoyos M, Sanges D, Iodice C, et al. (2007) Novel adeno-associated virus serotypes efficiently transduce murine photoreceptors. J Virol 81: 11372-11380.
38. Mussolino C, della Corte M, Rossi S, Viola F, Di Vicino U, et al. (2011) AAV-mediated photoreceptor transduction of the pig cone-enriched retina. Gene Ther 18: 637-645.
39. Wu J, Zhao W, Zhong L, Han Z, Li B, et al. (2007) Self-complementary recombinant adeno-associated viral vectors: packaging capacity and the role of rep proteins in vector purity. Hum Gene Ther 18: 171-182.
40. Lu H, Chen L, Wang J, Huack B, Sarkar R, et al. (2008) Complete correction of hemophilia A with adeno-associated viral vectors containing a full-size expression cassette. Hum Gene Ther 19: 648-654.
41. Dong B, Nakai H, Xiao W, (2010) Characterization of genome integrity for oversized recombinant AAV vector. Mol Ther 18: 87-92.
42. Lai Y, Yue Y, Duan D, (2010) Evidence for the failure of adeno-associated virus serotype 5 to package a viral genome>or = 8.2 kb. Mol Ther 18: 75-79.
43. Wu Z, Yang H, Colosi P, (2010) Effect of genome size on AAV vector packaging. Mol Ther 18: 80-86.
44. Grose WE, Clark KR, Griffin D, Malik V, Shontz KM, et al. (2012) Homologous Recombination Mediates Functional Recovery of Dysferlin Deficiency following AAV5 Gene Transfer. PLoS One 7: e39233.
45. McIntosh J, Lenting PJ, Rosales C, Lee D, Rabbanian S, et al. (2013) Therapeutic levels of FVIII following a single peripheral vein administration of rAAV vector encoding a novel human factor VIII variant. Blood 121: 3335-3344.
46. Kapranov P, Chen L, Dederich D, Dong B, He J, et al. (2012) Native molecular state of adeno-associated viral vectors revealed by single-molecule sequencing. Hum Gene Ther 23: 46-55.
47. Wang Y, Ling C, Song L, Wang L, Aslanidi GV, et al. (2012) Limitations of encapsidation of recombinant self-complementary adeno-associated viral genomes in different serotype capsids and their quantitation. Hum Gene Ther Methods 23: 225-233.
48. Lopes VS, Boye SE, Louie CM, Boye S, Dyka F, et al. (2013) Retinal gene therapy with a large MYO7A cDNA using adeno-associated virus. Gene Ther.
49. Dong X, Tian W, Wang G, Dong Z, Shen W, et al. (2010) Establishment of an AAV reverse infection-based array. PLoS One 5: e13479.
50. Fain GL, Matthews HR, Cornwall MC, Koutalos Y, (2001) Adaptation in vertebrate photoreceptors. Physiol Rev 81: 117-151.
51. Holland MG, Cambie E, Kloepfer W, (1972) An evaluation of genetic carriers of Usher's syndrome. Am J Ophthalmol 74: 940-947.
52. Sondheimer S, Fishman GA, Young RS, Vasquez VA, (1979) Dark adaptation testing in heterozygotes of Usher's syndrome. Br J Ophthalmol 63: 547-550.
53. Alexander KR, Fishman GA, (1984) Prolonged rod dark adaptation in retinitis pigmentosa. Br J Ophthalmol 68: 561-569.
54. Moore AT, Fitzke FW, Kemp CM, Arden GB, Keen TJ, et al. (1992) Abnormal dark adaptation kinetics in autosomal dominant sector retinitis pigmentosa due to rod opsin mutation. Br J Ophthalmol 76: 465-469.
55. Kemp CM, Jacobson SG, Roman AJ, Sung CH, Nathans J, (1992) Abnormal rod dark adaptation in autosomal dominant retinitis pigmentosa with proline-23-histidine rhodopsin mutation. Am J Ophthalmol 113: 165-174.
56. Sokolov M, Lyubarsky AL, Strissel KJ, Savchenko AB, Govardovskii VI, et al. (2002) Massive light-driven translocation of transducin between the two major compartments of rod cells: a novel mechanism of light adaptation. Neuron 34: 95-106.
57. Naash MI, Ripps H, Li S, Goto Y, Peachey NS, (1996) Polygenic disease and retinitis pigmentosa: albinism exacerbates photoreceptor degeneration induced by the expression of a mutant opsin in transgenic mice. J Neurosci 16: 7853-7858.
58. Cideciyan AV, (2010) Leber congenital amaurosis due to RPE65 mutations and its treatment with gene therapy. Prog Retin Eye Res 29: 398-427.
59. Ghosh A, Yue Y, Lai Y, Duan D, (2008) A hybrid vector system expands adeno-associated viral vector packaging capacity in a transgene-independent manner. Mol Ther 16: 124-130.
60. Reich SJ, Auricchio A, Hildinger M, Glover E, Maguire AM, et al. (2003) Efficient trans-splicing in the retina expands the utility of adeno-associated virus as a vector for gene therapy. Hum Gene Ther 14: 37-44.
61. Gruter O, Kostic C, Crippa SV, Perez MT, Zografos L, et al. (2005) Lentiviral vector-mediated gene transfer in adult mouse photoreceptors is impaired by the presence of a physical barrier. Gene Ther 12: 942-947.
62. Bainbridge JW, Stephens C, Parsley K, Demaison C, Halfyard A, et al. (2001) In vivo gene transfer to the mouse eye using an HIV-based lentiviral vector; efficient long-term transduction of corneal endothelium and retinal pigment epithelium. Gene Ther 8: 1665-1668.
63. Pang J, Cheng M, Haire SE, Barker E, Planelles V, et al. (2006) Efficiency of lentiviral transduction during development in normal and rd mice. Mol Vis 12: 756-767.